Recent Articles from GlobeNewswire

TORONTO, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Northland Power Inc. ("Northland" or the "Company") (TSX: NPI) today announced that pursuant to the share terms in respect of the Cumulative Rate Reset Preferred Shares, Series 1 (“Series 1 Shares”), it has determined the fixed dividend rate for the five years commencing September 30, 2025 and ending September 29, 2030. The fixed quarterly dividends on the Series 1 Shares during that period will be paid at an annual rate of 5.70% ($0.3564 per share per quarter).

FIELDBOSS, the all-in-one field service management platform built for HVAC, elevator, and specialty contractors, today announced the promotion of Corey Barss to Vice President of Operations.

VANCOUVER, British Columbia, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Newcore Gold Ltd. ("Newcore" or the "Company") (TSX-V: NCAU, OTCQX: NCAUF) announces the annual grant of equity incentive awards. Newcore has granted 2,815,000 stock options, 1,880,000 restricted share units and 525,000 performance share units (together the "Equity Incentive Awards") to employees, consultants, directors and executives of the Company. The stock options were granted at a price of $0.64 per share for a period of five years. The Equity Incentive Awards are subject to regulatory approval, are granted under the Company’s long-term incentive plan and are subject to vesting provisions.

LEQEMBI IQLIK is the first and only anti-amyloid treatment to offer an at-home injection to help patients and care partners continue to treat this progressive, relentless disease after initial treatment of 18 months

New York – August 29, 2025 – VEON Ltd. (Nasdaq: VEON) (“VEON), a global digital operator and parent company of Ukraine’s leading digital operator Kyivstar Group Ltd (Nasdaq: KYIV; KYIVW) (“Kyivstar”), today rang the opening bell on Nasdaq Stock Market (“Nasdaq”) in New York, capping a week of activities highlighting Kyivstar’s listing and the investment opportunities for Ukraine’s reconstruction.

REGULATED INFORMATION

DUBLIN, Ohio, Aug. 29, 2025 (GLOBE NEWSWIRE) -- reAlpha Tech Corp. (Nasdaq: AIRE) (“reAlpha” or the “Company”), an AI-powered real estate technology company, today announced that Chief Executive Officer Mike Logozzo and Chief Financial Officer Piyush Phadke will present at the H.C. Wainwright 27th Annual Global Investment Conference, taking place September 8–10, 2025, at the Lotte New York Palace Hotel in New York City.

NORWELL, Mass., Aug. 29, 2025 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. (“DIH” or the “Company”) (NASDAQ:DHAI) received a notice on August 26, 2025, from the Listing Qualifications Staff of The Nasdaq Stock Market LLC (“Nasdaq”), which stated that the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) because it had not filed its Report on Form 10-Q for the period ended June 30, 2025 (the “Form 10-Q”), and because the Company remains delinquent in filing its Form 10-K for the year ended March 31, 2025 (the “Form 10-K” and together with the Form 10-Q, the “Delinquent Reports”), with the Securities and Exchange Commission (“SEC”). Nasdaq Listing Rule 5250(c)(1) requires listed companies to timely file all required periodic financial reports with the SEC.

Shelton, CT, Aug. 29, 2025 (GLOBE NEWSWIRE) --

Operating expenses reduced 62% year-over-year and net loss narrowed by 59% as Rivalry completes second quarter under rebuilt, high-leverage model

HONG KONG, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Everbright Digital Holding Limited (the “Company” or “Everbright”) (Nasdaq: EDHL), an integrated marketing solutions provider headquartered in Hong Kong, confirmed that on August 25, 2025, it received a written notification (the "Notification Letter") from the Nasdaq Stock Market LLC ("Nasdaq"), notifying the Company that it is no longer in compliance with Nasdaq Listing Rule 5550(a)(2). Nasdaq Listing Rule 5550(a)(2) requires companies on the Nasdaq Capital Market to maintain a minimum bid price of at least $1 per share for continued listing.

NOVATO, Calif., Aug. 29, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for serious rare and ultra-rare genetic diseases, today announced participation in three upcoming investor conferences.

North America’s Premier Indoor Pickleball Franchise Expands Into Downtown Indianapolis

NEW YORK, Aug. 29, 2025 (GLOBE NEWSWIRE) --

Upland, CA, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Empower Dental Upland has officially opened its doors, marking the newest addition to the Empower Dental Group which operates practices across California. The opening reflects a mission to combine advanced dental technology, personalized care, and compassionate service in creating healthy, confident smiles for the Upland community.

Atlanta, GA, Aug. 29, 2025 (GLOBE NEWSWIRE) -- ScanTech AI Systems Inc. (the "Company" or "ScanTech AI") (Nasdaq: STAI), a leading innovator in advanced security screening technologies, today announced that the Company received a letter from Nasdaq Listing Qualifications of The Nasdaq Stock Market LLC (“Nasdaq”), related to non-compliance with a certain listing requirement.

Shelton, CT, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Hubbell Incorporated (NYSE: HUBB) today announced that Bill Sperry, Chief Financial Officer, will appear at the Morgan Stanley 2025 Laguna Conference. The event will be webcast and is scheduled to begin at 4:05PM PT on Thursday, September 11, 2025.

New rates take effect on Sept. 1, 2025 and Sept. 1, 2026.

VANCOUVER, British Columbia and BOSTON, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development, and commercialization of life-changing therapeutics for patients in need, today announced equity inducement grants to seven new non-officer employees consisting of an aggregate of 55,300 share options. All of the foregoing share options were approved by the Compensation Committee of the Company’s Board of Directors with an effective date of August 28, 2025 and were granted as inducements material to the employees entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4).

SAN DIEGO, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired Lockheed Martin Corporation (NYSE: LMT) securities between January 23, 2024 and July 21, 2025. Lockheed Martin is an aerospace defense company.

SAN DIEGO, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired Sarepta Therapeutics, Inc. (NASDAQ: SRPT) securities between June 22, 2023 and June 24, 2025. Sarepta is a commercial-stage biopharmaceutical company that focuses on RNA and gene therapies for the treatment of rare diseases. During the class period, Sarepta was engaged in the development of therapies to treat Duchenne muscular dystrophy (“Duchenne”), including ELEVIDYS. ELEVIDYS is a prescription gene therapy intended for a limited category of people with Duchenne.

SAN DIEGO, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of persons and entities that purchased or otherwise acquired PubMatic, Inc. (NASDAQ: PUBM) securities between February 27, 2025 and August 11, 2025. PubMatic is a technology company that enables real time programmatic advertising transactions for advertisers, agencies, and demand side platforms (“DSPs”).

SAN DIEGO, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of persons and entities that purchased or otherwise acquired LifeMD, Inc. (NASDAQ: LFMD) securities between May 7, 2025 and August 5, 2025. LifeMD is a leading provider of virtual primary care.

SAN DIEGO, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired Snap Inc. (NYSE:SNAP) securities between April 29, 2025 to August 5, 2025 (Case No. 2:25-CV-07844). Snap is a technology company best known for Snapchat, a visual messaging application.

RIYADH, Saudi Arabia, Aug. 29, 2025 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) is redefining global standards in robotic surgery, building on unprecedented world-firsts including the first fully robotic liver transplant led by Prof. Dieter Broering and the first fully robotic heart transplant performed by Prof. Feras Khaliel to advance a future where robotics becomes the preferred approach for complex procedures.

FORT WORTH, Texas, Aug. 29, 2025 (GLOBE NEWSWIRE) -- SEGG Media Corporation (NASDAQ: SEGG, LTRYW) (“SEGG Media” or the “Company”), a sports, entertainment and gaming conglomerate that owns Sports.com, Concerts.com, and Lottery.com, today announced the launch of its newly redesigned corporate website, seggmediacorp.com, a dynamic digital hub that signals the completion of the Company’s turnaround and the beginning of its next phase of aggressive growth.

HOUSTON, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Koil Energy Solutions, Inc. (OTCQB: KLNG), an international specialist in subsea equipment and services, today announces the award of a significant contract, which includes control equipment for a subsea isolation valve system. The purpose of the system is to protect the offshore platform and its personnel from the unintended release of hydrocarbons from subsea wells. The contract encompasses the engineering, procurement, and manufacturing of KOIL's robust and well-proven technical solution for Subsea Safety Control Systems.

Transaction in Own Shares   

PRESS RELEASE

NEW YORK, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Strata Critical Medical, Inc. (Nasdaq: SRTA, “Strata” or the “Company”), formerly known as Blade Air Mobility, Inc. (Nasdaq: BLDE) today announced that Will Heyburn, Co-Chief Executive Officer and Chief Financial Officer, will present at the 2025 Jefferies Industrials Conference on Thursday, Sept 4, 2025 at 11:30am ET. A webcast of the event will be available at the link here. A replay will be available shortly after the conclusion of the presentation on the investor relations section of the Company’s website at https://ir.stratacritical.com/news-events.

SOUTH SAN FRANCISCO, Calif., Aug. 29, 2025 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., ("ALX Oncology" or the "Company") (Nasdaq: ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat cancer and extend patients’ lives, today announced that ALX Oncology leadership will participate in both the Cantor Global Healthcare Conference 2025 and H.C. Wainwright 27th Annual Global Investment Conference in New York.

SEDA Experts LLC, a leading expert witness firm providing world-class financial consulting and expert witness services, announced today the launch of its International Tax, Accounting and Transactions Practice expanding its premier expertise into cross-border taxation, complex M&A transactions, and financial reporting.

Panaon Island declared a Protected Seascape, supporting marine life and coastal communities.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In SelectQuote To Contact Him Directly To Discuss Their Options

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In PubMatic To Contact Him Directly To Discuss Their Options

NEW YORK, Aug. 29, 2025 (GLOBE NEWSWIRE) --

NEW YORK, Aug. 29, 2025 (GLOBE NEWSWIRE) --

Joins Nasdaq listed VivoPower in Establishing Institutional XRP Income Model through Flare’s Smart Contract Infrastructure

Congratulations to this Year’s Building Futures Scholarship Program Awardees

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Unicycive To Contact Him Directly To Discuss Their Options

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Charter To Contact Him Directly To Discuss Their Options

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Nutex To Contact Him Directly To Discuss Their Options

NEW YORK, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against C3.ai, Inc. (“C3” or the “Company”) (NYSE: AI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

NEW YORK, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Ultragenyx Pharmaceutical Inc. (“Ultragenyx” or the “Company”) (NASDAQ: RARE).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.   

NEW YORK, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Mereo BioPharma Group plc (“Mereo” or the “Company”) (NASDAQ: MREO).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.   

NEW YORK, Aug. 29, 2025 (GLOBE NEWSWIRE) --

NEW YORK, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Necessity Retail REIT, Inc. (“Necessity Retail” or the “Company”) (NASDAQ: RTL) who received shares of Global Net Lease, Inc. (“Global Net Lease”) in connection with Global Net Lease’s acquisition of Necessity Retail on September 12, 2023 (the “Merger”).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  The J.M. Smucker Company (“Smucker” or the “Company”) (NYSE: SJM).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Simulations Plus, Inc. (“Simulations Plus” or the “Company”) (NASDAQ: SLP).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, Aug. 29, 2025 (GLOBE NEWSWIRE) --

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In CTO To Contact Him Directly To Discuss Their Options

NEW YORK, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Geely Automobile Holdings Limited (“Geely” or the “Company”) (OTCMKTS: GELYF; GELYY).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  ZEEKR Intelligent Technology Holding Limited (“Zeekr” or the “Company”) (NYSE: ZK).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Encompass Health Corporation (“Encompass” or the “Company”) (NYSE: EHC).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of GSK plc (“GSK” or the “Company”) (NYSE: GSK).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.   

Total Voting Rights

NEW YORK, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of MarineMax, Inc. (“MarineMax” or the “Company”) (NYSE: HZO).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.   

NEW YORK, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Barnes & Noble Education, Inc. (“Barnes & Noble” or the “Company”) (NYSE: BNED).   Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.   

NEW YORK, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Telix Pharmaceuticals Limited (“Telix” or the “Company”) (NASDAQ: TLX).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.   

NEW YORK, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Duolingo, Inc. (“Duolingo” or the “Company”) (NASDAQ: DUOL).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Exelixis, Inc. (“Exelixis” or the “Company”) (NASDAQ: EXEL).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Molina Healthcare, Inc. (“Molina” or the “Company”) (NYSE: MOH).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

WICHITA, Kan., Aug. 29, 2025 (GLOBE NEWSWIRE) -- Legend Senior Living®, a nationally recognized senior living provider headquartered in Wichita, KS, has announced the addition of two new residences to its growing portfolio, including its first location in Missouri. The company has assumed management of newly named The Vero of O’Fallon, located in St. Charles, Missouri, and The Glenwood of Gainesville in Gainesville, Florida.

NEW YORK, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Praxis Precision Medicines, Inc. (“Praxis” or the “Company”) (NASDAQ: PRAX).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Anika Therapeutics, Inc. (“Anika” or the “Company”) (NASDAQ: ANIK).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  NeoGenomics, Inc. (“NeoGenomics” or the “Company”) (NASDAQ: NEO).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Tronox Holdings plc  (“Tronox” or the “Company”) (NYSE: TROX).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Albany International Corp. (“Albany” or the “Company”) (NYSE: AIN).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Insperity, Inc. (“Insperity” or the “Company”) (NYSE: NSP).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Confluent, Inc.  (“Confluent” or the “Company”) (NASDAQ: CFLT).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

BALTIMORE, Aug. 29, 2025 (GLOBE NEWSWIRE) -- September is Prostate Cancer Awareness Month, and the Urology Care Foundation (UCF), the official foundation of the American Urological Association (AUA), is calling on people with prostates to shift into a PROstate of Mind: a reminder to be proactive, not reactive, when it comes to prostate health.

NEW YORK, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Fiserv, Inc. (“Fiserv” or the “Company”)(NYSE: FI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

NEW YORK, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Fortinet, Inc. (“Fortinet” or the “Company”) (NASDAQ: FTNT).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.